19 December 2001
No Evidence for Participation of Non-Adrenergic Non-Cholinergic Subtances in Brain Death-Related Hemodynamic Deterioration of the Feline Potential Heart Donor
GJ. Brandon Bravo Bruinsma, J.J. Bredee, T. J.C. Ruigrok, Van Echteld, J. H.H. ThijssenAnn Transplant 2001; 6(4): 43-47 :: ID: 497839
Abstract
Objective: The onset of brain death (BD) is associated with a hyperdynamic cardiovascular response caused by the acute sympathetic release of catecholamines. This is followed by progressive hemodynamic deterioration which may preclude heart donation for transplantation. The mechanism of the hemodynamic collapse is not fully understood. Changes in plasma concentrations of non-adrenergic non-cholinergic (NANC) substances. neuropeptide-Y (NP-Y. a vasoconstrictor) and the vasodilators calcitonin gene-related peptide (CGRP) and substance P (SP). were studied in relation to BD-related hemodynamic alterations. Materials and Methods: Cats (6 BD and 6 controls (C» were studied for 6 h. Heart rat~ (HR) and mean arterial pressure (MAP) were monitored. BD was induced at t = 0 min. At t = -5, 15.60, 180 and 360 min. 5 ml arterial blood samples were taken. The plasma was collected and analyzed. The correlations between MAP and NANC levels were calculated. Results: In the BD cats a maximal and significant increase in HR and MAP was observed at t = 2 min. HR returned to basal levels at t = 20 min and remained at that level. However. MAPdeteriorated progressively to 53:t8 mmHg (p 0.00 I vs C) at / =360 min. NP-Yhad increased from 59.7:t2.5 to 110:t20.2 pmoVI (p 0.05 vsC) at t = 15 min, had returned to basal value at t =60 min and remained at that level. CGR Plevels were lower and SP levels did not change vs C but both showed a trend towards higher levels at t =360 min. The correlations between MAP and NP- Y, CGRP and SP appeared to be not significant. Conclusion: No evidence for participation of NANC substances could be demonstrated in brain death-related hemodynamic deterioration of the feline potential heart donor
Keywords: Brain Death, hemodynamic response, Neuropeptides
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






